Your browser is no longer supported. Please, upgrade your browser.
AZN AstraZeneca PLC monthly Stock Chart
AstraZeneca PLC
Index- P/E43.13 EPS (ttm)0.95 Insider Own0.50% Shs Outstand2.60B Perf Week-1.70%
Market Cap106.52B Forward P/E18.75 EPS next Y2.19 Insider Trans0.00% Shs Float2.60B Perf Month7.79%
Income2.41B PEG2.23 EPS next Q0.40 Inst Own19.20% Short Float0.52% Perf Quarter-3.94%
Sales22.40B P/S4.75 EPS this Y-9.60% Inst Trans2.87% Short Ratio2.85 Perf Half Y11.15%
Book/sh4.14 P/B9.90 EPS next Y23.80% ROA3.90% Target Price45.10 Perf Year17.16%
Cash/sh1.91 P/C21.48 EPS next 5Y19.30% ROE20.30% 52W Range34.38 - 43.29 Perf YTD7.87%
Dividend1.40 P/FCF- EPS past 5Y-3.60% ROI10.90% 52W High-5.37% Beta0.52
Dividend %3.42% Quick Ratio0.60 Sales past 5Y-3.10% Gross Margin79.90% 52W Low19.17% ATR0.60
Employees64400 Current Ratio0.70 Sales Q/Q6.00% Oper. Margin16.90% RSI (14)62.73 Volatility1.26% 1.15%
OptionableYes Debt/Eq2.06 EPS Q/Q74.30% Profit Margin10.70% Rel Volume0.37 Prev Close41.40
ShortableYes LT Debt/Eq1.70 EarningsJul 26 BMO Payout146.10% Avg Volume4.69M Price40.97
Recom1.60 SMA203.45% SMA505.59% SMA2004.80% Volume1,737,004 Change-1.04%
Apr-02-19Downgrade UBS Neutral → Sell
Feb-05-19Initiated Exane BNP Paribas Outperform
Jan-25-19Upgrade Shore Capital Hold → Buy
Dec-11-18Resumed Jefferies Hold
Oct-09-18Initiated Guggenheim Buy
Aug-16-18Downgrade Jefferies Buy → Hold
Mar-19-18Upgrade Jefferies Hold → Buy
Feb-06-18Reiterated Leerink Partners Mkt Perform $36 → $38
Feb-05-18Reiterated Bernstein Outperform $40 → $42
Jan-18-18Reiterated Leerink Partners Mkt Perform $33 → $36
Dec-29-17Upgrade JP Morgan Neutral → Overweight
Oct-16-17Upgrade Credit Suisse Neutral → Outperform
Sep-25-17Upgrade Exane BNP Paribas Neutral → Outperform
Sep-22-17Upgrade Bernstein Mkt Perform → Outperform
Sep-14-17Downgrade Liberum Buy → Hold
Sep-06-17Upgrade Natixis Bleichroeder Neutral → Buy
Aug-09-17Upgrade Investec Hold → Buy
Jul-28-17Downgrade Morgan Stanley Overweight → Equal-Weight
May-12-17Upgrade Credit Suisse Underperform → Neutral
Apr-10-17Downgrade Jefferies Buy → Hold
Jun-24-19 08:33AM  Pfizer's Talzenna Gets Approval in Europe for Breast Cancer Zacks
Jun-21-19 09:07AM  Pharma Stock Roundup: PFE to Buy ARRY, RHHBY, MRK, AZN Drugs Get Regulatory Nod Zacks
06:27AM  Investors Chronicle: Telecom Plus, International Consolidated Airlines, AstraZeneca Financial Times
Jun-20-19 09:18AM  AstraZeneca's Triple-Combo COPD Inhaler Gets Japan's Nod Zacks
Jun-19-19 05:21PM  Ironwood's Linzess Lowers Abdominal Symptoms in IBS-C Patients Zacks
Jun-18-19 08:59AM  AstraZeneca/Merck's Lynparza Wins EU Nod for First-Line Use Zacks
03:05AM  AstraZeneca's Lynparza gets EU nod as first-line ovarian cancer maintenance treatment Reuters
03:02AM  UPDATE 1-AstraZeneca's Lynparza gets EU nod as first-line ovarian cancer maintenance treatment Reuters
02:35AM  AstraZeneca's Lynparza gets EU nod as first-line ovarian cancer maintenance treatment Reuters
Jun-17-19 09:51AM  AstraZeneca Gives Detailed Data From Calquence Leukemia Study Zacks
Jun-15-19 07:00AM  CALQUENCE® (acalabrutinib) Significantly Prolonged the Time Patients Lived without Disease Progression in Relapsed or Refractory Chronic Lymphocytic Leukemia Business Wire
Jun-14-19 06:00PM  Is AstraZeneca plc (AZN) A Good Stock To Buy? Insider Monkey
08:42AM  Pharma Stock Roundup: MRK Buys Small Cancer Biotech, RHHBY, MRK Drugs Get FDA Nod Zacks
07:00AM  LOKELMA Demonstrated Efficacy in Treating Hyperkalemia in Patients with End-Stage Renal Disease on Hemodialysis Business Wire
Jun-13-19 04:12PM  Amgen, Biogen, Gilead and Novo Nordisk have very high capacity for M&A, says Moodys MarketWatch
09:31AM  Keytruda & 4 Other Reasons to Invest in Merck's (MRK) Stock Zacks
Jun-10-19 09:57AM  The Zacks Analyst Blog Highlights: Bristol Myers, Merck, Roche, Lilly and AstraZeneca Zacks
08:00AM  FARXIGA Study Showed Reduced Progression of Kidney Disease or Renal Death in Patients with Type 2 Diabetes Business Wire
01:19AM  What Kind Of Shareholders Own AstraZeneca PLC (LON:AZN)? Simply Wall St.
Jun-07-19 11:53AM  New Sanofi CEO 2019: 8 Things to Know About Paul Hudson InvestorPlace
11:04AM  AstraZeneca's Calquence Meets Endpoint in 2nd CLL Study Zacks
10:21AM  Pharma Stock Roundup: ASCO Update, FDA Nod for LLY's Emgality for Cluster Headache Zacks
Jun-06-19 09:09AM  Was ASCO Quieter for Big Drug/Biotech Stocks This Year? Zacks
Jun-05-19 03:11PM  Cancer-Fighting Stocks & ETF: What You Need to Know Zacks
12:21PM  How Merck reached new ground in the fight against cancer Yahoo Finance Video
09:50AM  Ironwood Initiates Dosing in Mid-Stage Study for MD-7246 Zacks
09:09AM  Glaxo's Nucala Gets CHMP Nod for 2 Self-Administered Options Zacks
Jun-03-19 08:17PM  PRESS DIGEST- British Business - June 4 Reuters
03:14PM  AstraZeneca searches for successor to Chairman Johansson - Sky News Reuters
02:46PM  Why Cancer-Fighting Stocks & ETFs Are Soaring Zacks
02:29PM  AstraZeneca searches for successor to Chairman Johansson - Sky News Reuters
10:42AM  AstraZeneca's Imfinzi Shows Long-Term Benefits in Lung Cancer Zacks
04:11AM  Opening Quote: Kier has some nasty news for shareholders Financial Times
Jun-02-19 10:30PM  PRESS DIGEST- Financial Times - June 3 Reuters
01:10PM  Lynparza stalls pancreatic cancer in patients with BRCA mutations -study Reuters
12:09PM  Lynparza stalls pancreatic cancer in patients with BRCA mutations -study Reuters
09:00AM  IMFINZI® (Durvalumab) is the Only Immunotherapy to Demonstrate Overall Survival at Three Years in Unresectable, Stage III Non-Small Cell Lung Cancer Business Wire
12:42AM  AstraZeneca reports encouraging results for early-stage cancer treatments Financial Times
May-31-19 11:25AM  Why Inovio Pharmaceuticals Stock Is Sinking Today Motley Fool
May-29-19 03:29PM  Merck (MRK) Up This Year So Far: Will the Momentum Continue? Zacks
10:34AM  Allergan's (AGN) Vraylar Gets FDA Nod for Bipolar Depression Zacks
May-28-19 06:19PM  Inovio Pharma stock slips as AstraZeneca unit scales back agreement MarketWatch
12:29PM  Gaithersburgs Viela Bio strikes $220M deal with Chinese drug company American City Business Journals
12:50AM  Tesla, General Motors, Alibaba, and More: Why These Stocks Are in the Spotlight Insider Monkey
May-27-19 10:20AM  Novartis Gets FDA Nod for Breast Cancer Drug & Gene Therapy Zacks
May-22-19 07:00AM  Bob Harper and AstraZeneca Expand Survivors Have Heart Initiative to Empower and Unite Heart Attack Survivors Nationwide Business Wire
May-21-19 02:27AM  Despite Its High P/E Ratio, Is AstraZeneca PLC (LON:AZN) Still Undervalued? Simply Wall St.
May-20-19 12:31PM  Drugmakers lobbying spending at 10-year high as Washington targets soaring prices MarketWatch
08:00AM  FASENRA® (benralizumab) reduces oral corticosteroid use and maintains long-term efficacy and safety profile in severe eosinophilic asthma Business Wire
May-17-19 09:05AM  Rigel Initiates Enrollment in Pivotal Blood Disorder Study Zacks
May-16-19 08:00AM  AstraZeneca Continues to Redefine Cancer Treatment at The 2019 ASCO Annual Meeting Business Wire
May-15-19 09:07AM  3 Top Diabetes Stocks to Watch in May Motley Fool
May-14-19 11:51AM  AstraZeneca Needs New Breast Cancer Drug to be Blockbuster
May-11-19 02:51AM  AVEO Pharmaceuticals (AVEO) Q1 Earnings & Revenues Miss Mark Zacks
May-10-19 03:29PM  AVEO Pharmaceuticals (AVEO) Q1 Earnings & Revenues Miss Mark Zacks
10:21AM  Inovio (INO) Q1 Earnings & Revenues Fall Short of Estimates Zacks
07:34AM  Pharma Stock Roundup: AGN, NVO Report Q1 Earnings, NVS to Buy Takeda's Eye Drug Zacks
May-09-19 01:30AM  AstraZeneca Gets an $8 Billion Punishment Bloomberg
May-08-19 09:46AM  Clovis (CLVS) Q1 Earnings Top Estimates, Rubraca Sales Strong Zacks
07:00AM  AstraZeneca Teams Up with PGA Golf Champion Jason Day to Raise Awareness about the Importance of Biomarker Testing in Lung Cancer Business Wire
May-07-19 10:53AM  Guardant Health (GH) to Report Q1 Earnings: What's in Store? Zacks
May-03-19 09:00AM  Change Makers Across the Oncology Community Recognized at 2019 Cancer Community (C2) Awards Business Wire
08:36AM  Ironwood (IRWD) Q1 Earnings & Revenues Miss, Shares Fall Zacks
May-02-19 11:47AM  Edited Transcript of AZN.L earnings conference call or presentation 26-Apr-19 11:00am GMT Thomson Reuters StreetEvents
08:16AM  The Daily Biotech Pulse: FDA Nod For Sanofi's Dengue Vaccine, Veracyte Offering, Biogen Reports Positive Data Benzinga
03:05AM  AstraZeneca ties up with France's Transgene to develop viral immunotherapies Reuters
May-01-19 08:50AM  BenevolentAI starts AI collaboration with AstraZeneca to accelerate drug discovery TechCrunch
02:23AM  An Intrinsic Calculation For AstraZeneca PLC (LON:AZN) Suggests It's 46% Undervalued Simply Wall St.
Apr-30-19 01:00PM  Health Care Stocks: Buy Them While They're Down Kiplinger
11:39AM  AVEO Pharmaceuticals (AVEO) to Post Q1 Earnings: What's Up? Zacks
09:48AM  Merck (MRK) Beats on Q1 Earnings & Sales as Keytruda Shines Zacks
Apr-29-19 05:08PM  Better Big Pharma Stock: AbbVie vs. AstraZeneca Motley Fool
02:20PM  Md. biotech files to go public in up to $92M offering American City Business Journals
Apr-26-19 06:31PM  AstraZeneca PLC (AZN) Q1 2019 Earnings Call Transcript Motley Fool
04:20PM  This Drug Giant Nearly Doubled Its Earnings So Why Are Shares Slipping? Investor's Business Daily
11:13AM  This Drug Giant Nearly Doubled Its Earnings So Why Are Shares Slipping? Investor's Business Daily
10:59AM  AstraZeneca's (AZN) Q1 Earnings Beat, New Drugs Drive Sales Zacks
09:29AM  Sanofi (SNY) Q1 Earnings Top, Genzyme & Vaccines Drive Sales Zacks
09:23AM  AstraZeneca, RBS earnings weigh on London markets MarketWatch
06:45AM  Newer drugs fuel AstraZeneca quarterly sales beat Reuters
05:41AM  AstraZeneca's first quarter profits jump 74% Associated Press
05:41AM  Astrazeneca: 1Q Earnings Snapshot Associated Press
05:26AM  AstraZeneca first-quarter sales beat estimates on cancer drugs Reuters
03:58AM  AstraZeneca first-quarter sales beat estimates on cancer drugs Reuters
03:20AM  AstraZeneca Cancer Drug Sales Fuel Profit Beating Estimates Bloomberg
02:56AM  AstraZeneca cancer drugs drive growth in sales Financial Times
Apr-25-19 09:55AM  Bayer (BAYRY) Q1 Earnings Beat Estimates, Revenues Up Y/Y Zacks
Apr-24-19 12:00AM  AstraZeneca chief claims vindication five years after Pfizer bid Financial Times
Apr-23-19 10:44AM  What's in the Cards for AstraZeneca (AZN) in Q1 Earnings? Zacks
Apr-18-19 09:38AM  AVEO Pharmaceuticals Down More Than 40% in 90 Days: Here's Why Zacks
Apr-17-19 11:06AM  Top Ranked Income Stocks to Buy for April 17th Zacks
Apr-15-19 09:57AM  Clovis Stalls Mid-Stage Rubraca Study for Bladder Cancer Zacks
05:28AM  London's FTSE 100 tugged down by miners; IWG lifts midcaps Reuters
Apr-12-19 10:30AM  Pharma Stock Roundup: AZN, MRK, GSK Get Regulatory Approvals, Sandoz Inks New Deal Zacks
09:55AM  Dow 30 Stock Roundup: Procter & Gamble Hikes Dividend, Boeing Q1 Commercial Deliveries Fall Zacks
Apr-10-19 03:24PM  Here's what to expect from the stock market next month Investopedia
11:11AM  Is AstraZeneca Stock Worth Buying Before Earnings? InvestorPlace
10:46AM  Alkermes Reports Positive Data From Schizophrenia Study Zacks
10:20AM  J&J (JNJ) to Kick-start Pharma Q1 Earnings: What's in Store? Zacks
10:14AM  AstraZeneca/Merck's Lynparza Wins EU Nod for Breast Cancer Zacks
AstraZeneca PLC discovers, develops, and commercializes prescription medicines in the areas of oncology, cardiovascular, renal and metabolism, respiratory, autoimmunity, infection, neuroscience, and gastroenterology worldwide. Its marketed products include Arimidex, Casodex/Cosudex, Calquence, Faslodex, Imfinzi, Iressa, Lynparza, Nolvadex, Tagrisso, and Zoladex for oncology diseases; Atacand1/Atacand HCT/Atacand Plus, Brilinta/Brilique, Crestor, Plendil, Seloken/Toprol-XL, Tenormin, and Zestril for cardiovascular diseases; and Bydureon, Byetta, Farxiga/Forxiga, Kombiglyze XR, Komboglyze, Onglyza, Qtern, Symlin, Xigduo, and Xigduo XR for metabolic diseases. The company's marketed products also comprise Accolate, Bevespi Aerosphere, Bricanyl Respules, Bricanyl Turbuhaler, Daliresp/Daxas, Duaklir Genuair, Eklira Genuair/Tudorza Pressair, Fasenra, Oxis Turbuhaler, Pulmicort Turbuhaler/Pulmicort Flexhaler, Pulmicort Respules, Symbicort pMDI, Symbicort Turbuhaler, and Tudorza Pressair for respiratory diseases; Fluenz FluMist/Tetra Quadrivalen and Synagis3 for infection diseases; Movantik/Moventig, Seroquel IR, Seroquel XR, and Vimovo for neuroscience diseases; and Losec/Prilosec and Nexium for gastrointestinal diseases. The company serves primary care and specialty care physicians through distributors and local representative offices. AstraZeneca PLC has a collaboration and license option agreement with Transgene SA for clinical development and commercialization of novel oncolytic immunotherapies. The company was formerly known as Zeneca Group PLC and changed its name to AstraZeneca PLC in April 1999. AstraZeneca PLC was founded in 1992 and is headquartered in Cambridge, the United Kingdom.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
ASTRAZENECA PLC10% OwnerOct 22Buy5.00600,0003,000,0003,004,554Oct 24 04:16 PM
ASTRAZENECA PLC10% OwnerSep 28Buy15.00246,6663,699,9902,164,855Oct 02 09:35 PM